Cargando…

Editorial: Exploration of genetic variation, drug response, and interactions between gastrointestinal disorders and other diseases

Detalles Bibliográficos
Autores principales:	Tong, Shuangshuang, Lyu, Yanlin, Luo, Ruibang, Leung, Felix, Sha, Weihong, Chen, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535092/ https://www.ncbi.nlm.nih.gov/pubmed/37781699 http://dx.doi.org/10.3389/fphar.2023.1287441

Ejemplares similares

Genetically predicted causal associations between periodontitis and psychiatric disorders
por: Tong, Shuangshuang, et al.
Publicado: (2023)

Editorial: Gastrointestinal and Liver Effects of Fruits and Their Synergism With Drug Therapy: Exploring Possible Mechanisms of Action
por: Wanderley, Almir Gonçalves, et al.
Publicado: (2022)

Editorial: Medicinal plants in the treatment of gastrointestinal cancers: How can OMICS and other advanced approaches help in understanding their mechanisms of action?
por: Feng, Yibin, et al.
Publicado: (2022)

Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
por: Weiskirchen, Ralf, et al.
Publicado: (2022)

Editorial: Natural product treatment of gastrointestinal diseases
por: Sun, Mingyu, et al.
Publicado: (2022)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
por: Jiang, Rui, et al.
Publicado: (2023)

Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: He, Luying, et al.
Publicado: (2022)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: Frontiers Production Office,
Publicado: (2022)

Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022
por: Grasa, Laura, et al.
Publicado: (2022)

Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain
por: Lione, Lisa A., et al.
Publicado: (2022)

Editorial: Discovering novel anticancer molecules and revealing the pharmacological mechanism of gastrointestinal carcinoma
por: Xia, Yong, et al.
Publicado: (2022)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Editorial: Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function
por: Pandey, Amit V., et al.
Publicado: (2017)

Editorial: Advances in the potential treatments of gastrointestinal and liver diseases: addressing the public health burden
por: Turcu-Stiolica, Adina, et al.
Publicado: (2023)

Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications
por: Brusa, Paola, et al.
Publicado: (2022)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Editorial: Herbal medicines for gastrointestinal and hepatic diseases - novel pharmacological and toxicological approaches, Volume I
por: Hasnat, Muhammad, et al.
Publicado: (2023)

Editorial: Global excellence in ethnopharmacology: Asia
por: Arumugam, Somasundaram, et al.
Publicado: (2023)

Editorial: In silico Modeling of Brain Receptors for Antidepressants, Psychostimulants, and Other CNS-Active Drugs
por: Surratt, Christopher K., et al.
Publicado: (2016)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Editorial: New exploration for therapeutic tissue engineering grafts in the field of tissue regeneration
por: Yu, Tianhao, et al.
Publicado: (2023)

Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors
por: Qian, Yi, et al.
Publicado: (2019)

Editorial: Artificial Intelligence in Traditional Medicine
por: Wu, Chaoyong, et al.
Publicado: (2022)

Editorial: Natural Product Based Drugs that Control Obesity and Other Disorders that Trigger and Provoke Inflammation
por: Youssef, Fadia S., et al.
Publicado: (2022)

Editorial: Protection and healing in the digestive system and other tissues: Novel factors, mechanisms, and pharmaceutical targets
por: Brzozowski, Thomas, et al.
Publicado: (2022)

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
por: Baratta, Francesca, et al.
Publicado: (2023)

Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?
por: DeRango-Adem, Eva F., et al.
Publicado: (2021)

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders
por: Ayaz, Muhammad, et al.
Publicado: (2019)

Editorial: Exploration of Natural Product Leads for Multitarget-Based Treatment of Cancer—Computational to Experimental Journey
por: Singla, Rajeev K., et al.
Publicado: (2022)

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer
por: Feng, Liang, et al.
Publicado: (2023)

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
por: Zazuli, Zulfan, et al.
Publicado: (2018)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Editorial: Targeting Human Inflammatory Skin Diseases With Natural Products: Exploring Potential Mechanisms and Regulatory Pathways
por: Goh, Bey Hing, et al.
Publicado: (2021)

Editorial: Data mining and network-driven analysis: Drug discovery and mechanism exploration by targeting vascular dysfunction
por: Dai, Zhao, et al.
Publicado: (2022)

Editorial: Establishing Genetic Pleiotropy to Identify Common Pharmacological Agents for Common Diseases
por: O’Mara, Tracy A., et al.
Publicado: (2019)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Zeng, Ruijie, et al.
Publicado: (2021)

PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
por: Guo, Fusheng, et al.
Publicado: (2020)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jngd8dn7hgvqmm9f2pgbbni56r